Literature DB >> 29158571

Rheumatoid arthritis: Do TNF inhibitors influence lymphoma development?

Arthur Kavanaugh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29158571     DOI： 10.1038/nrrheum.2017.186

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  7 in total

Review 1.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

Review 2.  Advances in use of immunomodulatory agents--a rheumatology perspective.

Authors:  Minyoung Her; Arthur Kavanaugh
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-04-21       Impact factor: 46.802

3.  Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

Authors:  Eva Baecklund; Anastasia Iliadou; Johan Askling; Anders Ekbom; Carin Backlin; Fredrik Granath; Anca Irinel Catrina; Richard Rosenquist; Nils Feltelius; Christer Sundström; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2006-03

Review 4.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Authors:  Jasvinder A Singh; Kenneth G Saag; S Louis Bridges; Elie A Akl; Raveendhara R Bannuru; Matthew C Sullivan; Elizaveta Vaysbrot; Christine McNaughton; Mikala Osani; Robert H Shmerling; Jeffrey R Curtis; Daniel E Furst; Deborah Parks; Arthur Kavanaugh; James O'Dell; Charles King; Amye Leong; Eric L Matteson; John T Schousboe; Barbara Drevlow; Seth Ginsberg; James Grober; E William St Clair; Elizabeth Tindall; Amy S Miller; Timothy McAlindon
Journal:  Arthritis Rheumatol       Date:  2015-11-06       Impact factor: 10.995

5.  Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.

Authors:  W G Dixon; K D Watson; M Lunt; L K Mercer; K L Hyrich; D P M Symmons
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06       Impact factor: 4.794

6.  Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.

Authors:  Louise K Mercer; Anne C Regierer; Xavier Mariette; William G Dixon; Eva Baecklund; Karin Hellgren; Lene Dreyer; Merete Lund Hetland; René Cordtz; Kimme Hyrich; Anja Strangfeld; Angela Zink; Helena Canhao; M Victoria Hernandez; Florence Tubach; Jacques-Eric Gottenberg; Jacques Morel; Jakub Zavada; Florenzo Iannone; Johan Askling; Joachim Listing
Journal:  Ann Rheum Dis       Date:  2017-08-19       Impact factor: 19.103

7.  Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Authors:  Louise K Mercer; James B Galloway; Mark Lunt; Rebecca Davies; Audrey L S Low; William G Dixon; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2016-08-08       Impact factor: 19.103
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.